#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
Dr. Saum Sutaria, CEO of Tenet Healthcare, provides a masterclass on the complex U.S. healthcare system. He details its financial structure, historical evolution, and challenges like drug pricing and administrative burdens, connecting healthcare spending to broader economic issues and potential reforms.
Deep Dive Analysis
17 Topic Outline
US Healthcare System: Scale, Financing, and Structure
Historical Evolution: From Out-of-Pocket to Third-Party Payer
Medicare and Medicaid: Purpose, Coverage, and Impact
Employer-Sponsored Insurance and Consumer Choice
Healthcare Innovation and Rising Consumption
US Healthcare System Compared to Other Developed Nations
Physician Compensation and Workforce Capacity
PPO, HMO, and Kaiser: Understanding Insurance Models
Drug Pricing, PBMs, and Pharmaceutical Innovation
Sustainability of Healthcare Spending and US Economy
Health Outcomes: Life Expectancy Differences in the US
GLP-1 Drugs: Innovation, Affordability, and Economic Impact
Administrative Costs and Potential for Efficiency
Hospital Billing Complexity and Cost Reduction Opportunities
Affordable Care Act (ACA) and Uninsured Rates
Future Challenges: Long-Term Care and Neurocognitive Decline
Role of Technology and AI in Healthcare
6 Key Concepts
Employer-Sponsored Insurance
This is the dominant source of health coverage in the US, where employers procure health insurance for their employees. It became entrenched due to tax benefits codified in 1954, making it a pre-tax benefit and incentivizing its growth by socializing risk among employee groups.
Moral Hazard (in healthcare)
This economic concept describes how the socialization of healthcare costs, through insurance, makes consumers less sensitive to the actual price points of services, drugs, and hospitalizations. This detachment from direct cost can drive up consumption and overall expenditures.
PBM (Pharmacy Benefit Manager)
PBMs are intermediaries that manage drug benefits for insurers and employers, negotiating prices with pharmaceutical companies and pharmacies. They create formularies and manage benefit plans, often earning rebates from pharma companies, which can complicate drug pricing transparency.
DRG (Diagnosis-Related Group)
A DRG is a single, bundled reimbursement payment for a hospital stay or procedure, covering technical fees, drugs, ICU stay, and other services. This system, a government innovation from Medicare, has largely replaced fragmented billing for many commercial services.
Value-Based Care
This concept aims to shift healthcare reimbursement from a fee-for-service model to one that rewards outcomes and population health. While many initiatives have been tried, most have not succeeded in fundamentally changing workflows or significantly reducing costs, with Medicare Advantage being a notable exception.
Charge Master
A charge master is a comprehensive list of prices for every service, supply, and procedure a hospital or doctor's office offers, required by federal regulation. These listed 'charges' are often artificially high and do not reflect the actual negotiated prices paid by insurance companies or Medicare, leading to opaque billing practices.
9 Questions Answered
Roughly one-fourth of the $4 trillion annual expenditure comes from consumers, another one-fourth from employers (primarily through employer-sponsored insurance), and the remaining half from government sources (federal and state, including direct spending and tax subsidies).
The US system prioritizes consumer choice, immediate access, and innovation, which, combined with the socialization of costs through insurance, drives higher consumption and prices. Other developed nations typically manage costs through supply-side interventions and price controls.
In the 1950s, the US spent less than 5% of GDP on healthcare, with over half paid out-of-pocket. Key developments include the Hill-Burton Act for hospital capacity, the 1954 codification of tax benefits for employer-sponsored insurance, and the 1965 creation of Medicare and Medicaid to cover seniors and low-income individuals.
PBMs act as intermediaries between pharmaceutical companies, insurers, and pharmacies, managing formularies and negotiating rebates. This system can create opaque pricing, where incentives may exist for higher-priced drugs with larger rebates, rather than lower sticker prices.
The lower overall life expectancy is primarily driven by higher infant mortality, injuries, homicides, and drug/substance abuse issues in younger populations, combined with a higher prevalence of chronic illnesses like obesity and diabetes. However, life expectancy for Americans over 70 is among the highest in the developed world.
Administrative costs account for 10-15% of total healthcare spending in the US, a significantly higher proportion than in other countries. This complexity is partly a trade-off for consumer choice and the multi-payer system, but it also represents a major area for potential efficiency gains, possibly through technology like AI.
A PPO (Preferred Provider Organization) plan offers broad network choice, allowing individuals to see any provider, often with a discount for preferred networks. An HMO (Health Maintenance Organization) plan narrows choice, requiring individuals to stay within a specific network or face higher penalties, theoretically at a lower cost.
While GLP-1 drugs are effective for obesity and type 2 diabetes, their high cost poses a significant economic challenge. From a macroeconomic perspective, applying these drugs to economically productive individuals (under 65) could improve health status and productivity, potentially offsetting costs, whereas their long-term impact on costs for the elderly is less clear.
The biggest challenge is the management and care of neurocognitive decline, including dementia, given the aging population. Traditional pharmaceutical models may be limited by the blood-brain barrier, necessitating new forms of innovation, particularly engineering-based solutions and improved custodial care models.
37 Actionable Insights
1. Improve Nutrition, Physical Activity
Make fundamental changes to your nutritional environment and incorporate even a modest degree of physical activity into your daily routine, as these behavioral shifts can significantly improve health span and reduce long-term healthcare costs related to chronic illness.
2. Address Root Causes of Poor Health
Advocate for and support efforts to address societal issues like infant mortality, drug abuse, violence, and chronic illness directly, as these factors significantly drive poor health outcomes and are not primarily solved by insurance or healthcare system changes alone.
3. Avoid Being Uninsured
To protect yourself from exorbitant ‘sticker prices’ for medical services and supplies, ensure you have health insurance, as it acts as a ‘discount card’ providing access to negotiated group rates that uninsured individuals do not receive.
4. Reframe Healthcare Insurance View
Shift your perception of healthcare insurance from covering random, infrequent, and unpredictable events to viewing it as a ‘discount card’ for predictable, ongoing health needs, as this reflects its current function in the U.S. system.
5. Recognize Healthcare Cost Insensitivity
Understand that the socialization of healthcare costs through insurance has made American consumers less sensitive to the actual price points of services, drugs, and hospitalizations, which can lead to increased consumption.
6. Utilize ACA Exchanges
If your employer doesn’t offer insurance and you don’t qualify for Medicaid, explore options on the Affordable Care Act (ACA) exchanges, which are designed to provide more affordable group coverage by socializing risk.
7. Understand Insurance Plan Types
During open enrollment, familiarize yourself with different insurance plan types like PPO (Preferred Provider Organization) for open network choice and HMO (Health Maintenance Organization) for narrowed choice with potential cost savings, to make an informed decision.
8. Prioritize Choice or Cost
When selecting health insurance, understand that PPO plans offer more choice but often come at a higher cost, while HMOs restrict choice for theoretical cost savings; decide which priority aligns best with your needs.
9. Seek Outpatient Care
Whenever medically appropriate, opt for procedures and care in lower-cost outpatient settings (like ambulatory surgery centers) rather than hospitals, as this can significantly reduce per-unit costs and improve convenience.
10. Advocate Drug Price Negotiation
Support policies that allow government entities like Medicare to negotiate drug prices, as this could help curb rising pharmaceutical expenditures and align U.S. drug costs more closely with other developed nations.
11. Support Large-Scale Purchasing Power
Advocate for and support the use of large-scale purchasing power by major entities (like Medicare) to negotiate better prices for healthcare services and drugs, as this is a market-based approach that can drive efficiency and innovation.
12. Scrutinize PBM Practices
Be aware that Pharmacy Benefit Managers (PBMs) operate as intermediaries in drug pricing, and their rebate structures can create incentives that may lead to higher drug prices, warranting scrutiny of their practices and advocating for transparency.
13. Leverage AI for Admin Efficiency
Explore and advocate for the responsible implementation of AI and automation in healthcare administration to reduce costs and improve efficiency in areas like claims processing, while ensuring appropriate controls and oversight.
14. Implement AI with Careful Controls
When advocating for or implementing AI in healthcare, ensure robust controls are in place to prevent negative consequences such as over-coding or under-authorization of care, balancing efficiency gains with ethical considerations and patient needs.
15. Support Long-Term Government Health
Advocate for and support government-led initiatives aimed at improving national health objectives over a 10-year period, as such long-term investments are beyond the scope of individual or employer-funded programs but are crucial for societal health improvement.
16. Define National Health Objectives
Engage in discussions to establish clear national health objectives, as a defined goal is essential for guiding policy, funding, and interventions to effectively address the country’s health challenges.
17. Invest in Neuro-Engineering Solutions
Support and invest in engineering-based solutions and device therapies (e.g., neurostimulation) for neurocognitive decline and neurological diseases, as these innovations are crucial for managing an aging population’s care needs given the limitations of traditional drug discovery.
18. Support Home-Based Dementia Care
Advocate for and develop new models for custodial care that make it easier for families to provide care in the household, and support engineering solutions that enhance cognitive function to increase self-sufficiency for those with dementia, reducing reliance on expensive institutional care.
19. Grasp Healthcare’s Economic Impact
Recognize that discussions about the economy, inflation, and jobs are inherently discussions about healthcare, as it constitutes almost 20% of the U.S. economy, making it a critical factor in broader economic understanding.
20. Recognize Interconnectedness of Issues
Understand that seemingly unrelated societal issues, such as border policy, have direct implications for healthcare outcomes and costs, highlighting the interconnected nature of macroeconomic and social challenges with health.
21. Engage Long-Term Healthcare Planning
Recognize that fundamental issues in the U.S. healthcare system require long-term planning and discussion, as quick fixes are unlikely to succeed, and proactive engagement is needed to avoid future crises.
22. Seniors: Explore Medicare Advantage
For seniors seeking more product and benefit choices beyond traditional Medicare, investigate Medicare Advantage plans, which are designed to offer additional options and potentially better benefits.
23. Consider Integrated Care Models
Explore integrated care models like Kaiser Permanente, where you agree to stay within their network of providers and facilities, which aims to offer lower costs or better outcomes through care integration.
24. Explore Managed Care Options
If cost control is a priority, consider managed care programs (like HMOs) offered by insurance companies, as they have demonstrated an ability to manage costs, albeit sometimes with trade-offs in choice and flexibility.
25. Managed Care for Rare Conditions
If considering managed care, be aware that for esoteric or rare medical problems, physicians typically have the ability to refer patients to out-of-network specialists, ensuring access to appropriate expertise.
26. Understand Medical Billing Charges
Be aware that the ‘charge’ on a medical bill (e.g., $16 for gauze) is an artificial construct and does not reflect the actual cost or the negotiated price paid by insurers, which is typically much lower due to group discounts.
27. Be Aware GLP-1 Muscle Loss
If considering GLP-1 agonists, especially for elderly individuals, be mindful of the potential for muscle loss, which can have significant health consequences like increased risk of hip fractures and mortality.
28. Physicians: Seek Drug Cost Awareness
As a prescribing physician, acknowledge the lack of transparency regarding drug costs and consider advocating for or seeking information that would allow for more cost-conscious prescribing decisions.
29. Leverage EMR Foundation with AI
Recognize the electronic medical record (EMR) as a foundational system of record, and focus on leveraging it with AI to build systems of engagement, improve clinical care, and enhance evidence-based medicine, rather than expecting EMRs alone to transform quality, access, or choice.
30. Maintain Long-Term AI Optimism
While acknowledging short-term hype, maintain a long-term optimistic perspective on the potential of AI to significantly improve clinical care and not just administrative costs in healthcare.
31. Appreciate Effective Government Regulation
Acknowledge that while healthcare may be overregulated in some areas, government-mandated quality and safety standards (e.g., for sepsis care) have significantly improved the consistency and performance of the U.S. healthcare system.
32. Recognize Healthcare Cross-Subsidies
Understand that the U.S. healthcare system relies on cross-subsidies, where healthy individuals and employer-sponsored insurance (paying higher rates) effectively subsidize care for the ill and those covered by government programs like Medicare and Medicaid.
33. Understand Nationalized System Trade-offs
When comparing healthcare systems, recognize that nationalized models often involve longer wait times and reduced choice for elective procedures, but generally maintain high quality for emergency and specialized care.
34. Encourage Proactive Self-Regulation
Recognize that industries operating in wide-parameter free markets, like pharmaceuticals, face a choice: proactively adjust practices (e.g., drug pricing) to stay within acceptable societal parameters or risk external intervention and regulation.
35. Prepare for Coverage Re-evaluation
Anticipate that rising healthcare costs, particularly for new drugs, may force a re-evaluation of what services and treatments insurance models can cover, potentially leading to difficult decisions about coverage limits.
36. Recognize Family Long-Term Care Role
Understand that families in the U.S. bear a significant burden of long-term care for the elderly, which, while culturally positive, also represents lost wages and productivity in the economy.
37. Prioritize GLP-1 for Working-Age
From an economic perspective, consider prioritizing the application of GLP-1 drugs for working-age individuals to improve health status and economic productivity, rather than solely focusing on those over 65 where the long-term cost-benefit is less clear.
7 Key Quotes
Insurance today is a discount card. It's not insurance in healthcare. Insurance traditionally would be in other parts of your life where you procure insurance for random, infrequent, and unpredictable events.
Sam Sutaria
The U.S. healthcare system in many ways is a story, an optimistic story of well-intended policies that now are questioned based upon the way the expenditures have increased.
Sam Sutaria
Show me how a man gets paid and I'll tell you exactly how he's going to act.
Peter Attia
For better or for worse, right or wrong, nowhere in the world, no matter what healthcare system you're in, in a developed country, do you have fully equitable access. Those with means, there is always a system to procure better access from that perspective.
Sam Sutaria
This isn't an insurance coverage problem. I mean, we pretty much cover everybody other than undocumented today in the US or people that choose not to get covered because there are options now for everybody. And in some states, we're even covering undocumented. It's not a coverage problem.
Sam Sutaria
The border is a healthcare issue. It just is. You can't escape it. Everything ties back in one form or another to healthcare.
Sam Sutaria
The single most optimistic thing I take away from this is we might not have to slash the cost by something dramatic like 25%. If we can enact the right combination of policies, technologies, perturbations in behaviors and incentives that simply bend the cost curve towards GDP growth, we might actually be fine in the long run.
Peter Attia